Literature DB >> 32110674

Erdheim-Chester disease with asymmetric talus involvement: A case report.

Qin Xia1, Cheng Tao1, Ke-Wei Zhu1, Wei-Ye Zhong1, Peng-Lin Li1, Yi Jiang2, Min-Zhi Mao3.   

Abstract

BACKGROUND: Erdheim-Chester disease (ECD) is a rare multi-system or multi-organ histiocytic proliferative disease with diverse clinical manifestations, and the development of the disease is complex, which makes clinical diagnosis and treatment difficult. The characteristic clinical manifestations include multi-organ involvement, especially in the symmetrical diaphysis and metaphysis of the bilateral extremities. ECD with a unilateral talus lesion is extremely rare. Here, we report an unusual case of ECD invading the asymmetric talus and tibia without involving other organs. The patient had good outcome after surgery. CASE
SUMMARY: We report a case of a 67-year-old man who was referred to our outpatient department because of left ankle chronic pain for 5 years, which exacerbated after a foot sprain 6 mo previously. We discovered multiple sclerotic lesions of the tibia and talus on his previous X-ray films, which were initially missed in a local hospital. Therefore, enhanced computer computed tomography (CT) and magnetic resonance imaging were performed. These examinations showed multiple lesions in the bone marrow cavity of the left tibia, and cortical sclerosis and osteonecrosis of the left talus. Specimens were collected via bone puncture from the two lesions, and a final diagnosis of ECD was confirmed by pathological and immunohistochemical examinations. In addition, other auxiliary examinations including head CT, pulmonary CT, spinal CT, abdominal CT, cardiac ultrasound and thyroid ultrasound showed no obvious abnormalities. The patient underwent surgery for the tibia lesion scraping and talus lesion scraping combined with cement casting. The patient started on a progressive rehabilitation at 4 wk, and felt no pain after surgery. During a 2-year follow-up period, the patient exercised normally without pain, and there were no signs of recurrence.
CONCLUSION: This study shows that surgery treatment may also achieve good results for ECD patients with only bone involvement. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Case report; Erdheim-Chester disease; Osteosclerosis; Surgery; Talus; Tibia

Year:  2020        PMID: 32110674      PMCID: PMC7031838          DOI: 10.12998/wjcc.v8.i3.614

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  25 in total

Review 1.  Surgical treatment of intracranial Erdheim-Chester disease.

Authors:  Alex Alfieri; Roberto Gazzeri; Marcelo Galarza; Massimiliano Neroni
Journal:  J Clin Neurosci       Date:  2010-09-16       Impact factor: 1.961

Review 2.  Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.

Authors:  Matthias Papo; Fleur Cohen-Aubart; Ludovic Trefond; Adeline Bauvois; Zahir Amoura; Jean-François Emile; Julien Haroche
Journal:  Curr Oncol Rep       Date:  2019-05-21       Impact factor: 5.075

3.  Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort.

Authors:  Fleur Cohen-Aubart; Jean-François Emile; Fabrice Carrat; Zofia Helias-Rodzewicz; Valérie Taly; Frédéric Charlotte; Philippe Cluzel; Jean Donadieu; Ahmed Idbaih; Stéphane Barete; Zahir Amoura; Julien Haroche
Journal:  Am J Hematol       Date:  2018-02-10       Impact factor: 10.047

4.  Compression of kidneys in Erdheim-Chester disease of retroperitoneum: Open surgical approach.

Authors:  Thomas Florian Wimpissinger; Guntram Schernthaner; Hans Feichtinger; Walter Stackl
Journal:  Urology       Date:  2005-04       Impact factor: 2.649

Review 5.  Erdheim-Chester disease.

Authors:  Corrado Campochiaro; Alessandro Tomelleri; Giulio Cavalli; Alvise Berti; Lorenzo Dagna
Journal:  Eur J Intern Med       Date:  2015-04-10       Impact factor: 4.487

6.  Erdheim-Chester disease in a female cardiac surgery patient.

Authors:  H R Mahoozi; A Zittermann; K Hakim Meibodi; W Burchert; J F Gummert; N Mirow
Journal:  Thorac Cardiovasc Surg       Date:  2011-05-18       Impact factor: 1.827

Review 7.  Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary.

Authors:  R Carpinteri; I Patelli; F F Casanueva; A Giustina
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-10       Impact factor: 4.690

8.  Erdheim-Chester disease with bilateral Achilles tendon involvement.

Authors:  Jonathan Nadjiri; Klaus Woertler; Katja Specht; Norbert Harrasser; Andreas Toepfer
Journal:  Skeletal Radiol       Date:  2016-08-10       Impact factor: 2.199

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.

Authors:  Eli L Diamond; Vivek Subbiah; A Craig Lockhart; Jean-Yves Blay; Igor Puzanov; Ian Chau; Noopur S Raje; Jurgen Wolf; Joseph P Erinjeri; Jean Torrisi; Mario Lacouture; Elena Elez; Ferran Martínez-Valle; Benjamin Durham; Maria E Arcila; Gary Ulaner; Omar Abdel-Wahab; Bethany Pitcher; Martina Makrutzki; Todd Riehl; José Baselga; David M Hyman
Journal:  JAMA Oncol       Date:  2018-03-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.